Skip to content

    Recently Viewed


      Home /
      Johnson & Johnson to Host Pharmaceutical Business Review

      Johnson & Johnson to Host Pharmaceutical Business Review

      Share Article
      share to

      NEW BRUNSWICK, N.J., April 20, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceutical business for the investment community beginning at 8:30 a.m. (Eastern Time) on Wednesday, May 20, 2015 at the Hyatt Regency Hotel in New Brunswick, New Jersey and ending at approximately 3:00 p.m.

      Paul Stoffels, M.D., Worldwide Chairman Pharmaceuticals, and Chief Scientific Officer and Joaquin Duato, Worldwide Chairman, Pharmaceuticals will host the meeting. Dominic Caruso, Vice President, Finance and Chief Financial Officer will provide opening remarks. The meeting will feature presentations from the therapeutic area leaders within the Pharmaceutical Research and Development organization.

      The agenda for the day will be posted on the Investor Relations website on approximately May 13th.

      Investors and other interested parties may access this meeting by visiting the Company’s website at for a simultaneous webcast of the presentations.

      A replay and podcast will be available shortly after the live webcast through

      SOURCE Johnson & Johnson

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.